Such observations have been supported by the demonstration of increased tumour invasiveness and accelerated metastatic ‘conditioning’, amongst animal cancer models subject to anti‐VEGF administration (Ebos et al., 2009; Pàez‐Ribes et al., 2009). Here, VEGFA is linked to cancer.